ESOPHAGUS CANCER
Clinical trials for ESOPHAGUS CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGUS CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGUS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune drug targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug, CRPA1A2, that helps the immune system attack cancer cells. It is for people with certain advanced solid tumors (like lung, esophagus, head and neck, or liver cancer) who have a specific genetic marker (HLA-A*02:01 and MAGE-A1). The main go…
Matched conditions: ESOPHAGUS CANCER
Phase: PHASE1 • Sponsor: Corregene Biotechnology Co., Ltd • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New imaging technique could reveal how cancer drugs reach tumors
Diagnosis Not yet recruitingThis study will use a special PET scan to track where the drug ivonescimab goes in the body of people with esophageal cancer. The goal is to see if the drug reaches the tumor and how it spreads, which could help doctors choose better treatments. About 50 adults with esophageal ca…
Matched conditions: ESOPHAGUS CANCER
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated May 11, 2026 20:48 UTC